JP2010120974A5 - - Google Patents

Download PDF

Info

Publication number
JP2010120974A5
JP2010120974A5 JP2010040362A JP2010040362A JP2010120974A5 JP 2010120974 A5 JP2010120974 A5 JP 2010120974A5 JP 2010040362 A JP2010040362 A JP 2010040362A JP 2010040362 A JP2010040362 A JP 2010040362A JP 2010120974 A5 JP2010120974 A5 JP 2010120974A5
Authority
JP
Japan
Prior art keywords
group
isoxazole
pyrimidinyl
acetylamino
methylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010040362A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010120974A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010040362A priority Critical patent/JP2010120974A/ja
Priority claimed from JP2010040362A external-priority patent/JP2010120974A/ja
Publication of JP2010120974A publication Critical patent/JP2010120974A/ja
Publication of JP2010120974A5 publication Critical patent/JP2010120974A5/ja
Pending legal-status Critical Current

Links

JP2010040362A 2007-02-16 2010-02-25 微粒子油性懸濁液を含む医薬組成物 Pending JP2010120974A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010040362A JP2010120974A (ja) 2007-02-16 2010-02-25 微粒子油性懸濁液を含む医薬組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007035916 2007-02-16
JP2010040362A JP2010120974A (ja) 2007-02-16 2010-02-25 微粒子油性懸濁液を含む医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008558013A Division JP4588791B2 (ja) 2007-02-16 2008-02-15 微粒子油性懸濁液を含む医薬組成物

Publications (2)

Publication Number Publication Date
JP2010120974A JP2010120974A (ja) 2010-06-03
JP2010120974A5 true JP2010120974A5 (https=) 2011-02-03

Family

ID=39689861

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008558013A Expired - Fee Related JP4588791B2 (ja) 2007-02-16 2008-02-15 微粒子油性懸濁液を含む医薬組成物
JP2010040362A Pending JP2010120974A (ja) 2007-02-16 2010-02-25 微粒子油性懸濁液を含む医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008558013A Expired - Fee Related JP4588791B2 (ja) 2007-02-16 2008-02-15 微粒子油性懸濁液を含む医薬組成物

Country Status (9)

Country Link
US (1) US8309138B2 (https=)
EP (1) EP2123255B1 (https=)
JP (2) JP4588791B2 (https=)
KR (1) KR101434706B1 (https=)
CN (1) CN101610754A (https=)
AU (1) AU2008215659B2 (https=)
CA (1) CA2677842C (https=)
ES (1) ES2423929T3 (https=)
WO (1) WO2008099615A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101814186B1 (ko) 2008-09-17 2018-03-14 키아스마 인코포레이티드 약제학적 조성물 및 연관된 투여방법
CN103655512B (zh) * 2013-12-12 2015-05-20 海南海力制药有限公司 一种硝酸芬替康唑阴道软胶囊及其制备方法
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
WO2019022152A1 (ja) 2017-07-26 2019-01-31 学校法人同志社 TGF-βシグナルに起因する障害を治療または予防するための医薬およびその応用
WO2019036663A1 (en) * 2017-08-17 2019-02-21 University Of Delaware FURANE COMPOSITIONS AND METHODS OF MAKING THE SAME
BR112020006677A2 (pt) 2017-10-05 2020-10-06 Fulcrum Therapeutics, Inc. uso de inibidores p38 para reduzir a expressão de dux4
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8546591A (en) * 1990-09-13 1992-04-15 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
MX9300141A (es) 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
JPH0616556A (ja) 1992-07-02 1994-01-25 Yoshitomi Pharmaceut Ind Ltd 難溶性薬物含有製剤
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
JPH07138151A (ja) 1993-11-15 1995-05-30 Kanebo Ltd ソフトカプセル剤及びその製造方法
BR9607035A (pt) 1995-02-13 1997-11-04 Searle & Co Isoxazois substituidos para o tratamento de inflamação
JPH1081621A (ja) 1996-04-01 1998-03-31 Takeda Chem Ind Ltd 経口投与用医薬組成物
WO1998007414A1 (en) 1996-08-22 1998-02-26 Research Triangle Pharmaceuticals Ltd. Compositions comprising microparticles of water-insoluble substances and method for preparing same
US5736151A (en) 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
AU754830C (en) 1997-05-22 2004-02-12 G.D. Searle Llc Substituted pyrazoles as p38 kinase inhibitors
CA2320087C (en) * 1998-02-09 2006-12-19 Joel Bolonick Treatment of chronic inflammatory disorders of the gastrointestinal tract
JPH11302156A (ja) 1998-04-16 1999-11-02 Tanabe Seiyaku Co Ltd ポリペプチドの微粒子化方法
JP4191825B2 (ja) 1998-09-10 2008-12-03 あすか製薬株式会社 5−アミノイソキサゾール誘導体
PE20001227A1 (es) 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
JP2002533378A (ja) * 1998-12-23 2002-10-08 アムジエン・インコーポレーテツド タンパク質の徐放用ポリオール/油懸濁液
KR100711538B1 (ko) 1998-12-25 2007-04-27 아스카 세이야쿠 가부시키가이샤 아미노피라졸 유도체
WO2000040220A1 (en) * 1999-01-06 2000-07-13 Korea Research Institute Of Chemical Technology Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same
BR0008403A (pt) 1999-02-23 2002-01-29 Merck & Co Inc Formulação farmacêutica para administração oral
DE60033028T2 (de) 1999-04-23 2007-11-15 Takeda Pharmaceutical Co. Ltd. 5-pyridyl-1,3-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung
ATE284205T1 (de) 1999-10-01 2004-12-15 Natco Pharma Ltd Magensaftresistente gelartige weichkapsel
IN192188B (https=) 2000-06-16 2004-03-13 Ranbaxy Lab Ltd
DE10041479A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
AU2001289438A1 (en) * 2000-09-22 2002-04-02 Galephar M/F Pharmaceutical semi-solid composition of isotretinoin
PL371133A1 (en) 2001-12-20 2005-06-13 Pharmacia Corporation Pharmaceutical suspension for oral administration
EP1490025B1 (en) 2002-03-20 2008-02-13 Elan Pharma International Limited Nanoparticulate compositions of map kinase inhibitors
GB0214268D0 (en) 2002-06-20 2002-07-31 Celltech R&D Ltd Chemical compounds
AU2003251661A1 (en) 2002-08-06 2004-02-25 F. Hoffmann-La Roche Ag 6-alkoxy-pyrido-pyrimidines as p-38 map kinase inhibitors
DE10237883A1 (de) 2002-08-19 2004-03-04 Merckle Gmbh Chem.-Pharm. Fabrik Substituierte Isoxazolderivate und ihre Verwendung in der Pharmazie
TW200412948A (en) 2002-08-23 2004-08-01 Ionix Pharmaceuticals Ltd Therapeutic compounds
JP2004099442A (ja) 2002-09-04 2004-04-02 Nisshin Pharma Inc 難溶性薬物含有製剤およびその製造方法
EP1546141A1 (en) 2002-09-06 2005-06-29 Vertex Pharmaceuticals Incorporated Isoxazoles and their use in the treatment of ischemic diseases
MXPA05006670A (es) 2002-12-18 2005-10-19 Algorx Pharmaceuticals Inc Administracion de capsaicinoides.
US7550480B2 (en) 2003-02-14 2009-06-23 Smithkline Beecham Corporation Compounds
EP1601672B1 (en) 2003-02-14 2006-07-26 Pfizer Products Inc. Triazolo-pyridines as anti-inflammatory compounds
JPWO2004073692A1 (ja) 2003-02-18 2006-06-01 山下 伸二 難水溶性薬物のハードカプセル剤
JP2005013938A (ja) 2003-06-27 2005-01-20 Canon Inc 脱色装置及び方法
US20060151899A1 (en) 2003-08-06 2006-07-13 Akira Kato Process for producing drug ultramicroparticle and apparatus therefor
JP5096658B2 (ja) 2003-10-06 2012-12-12 株式会社三協 生物学的利用能を向上させたソフトカプセル
GB0402143D0 (en) 2004-01-30 2004-03-03 Smithkline Beecham Corp Novel compounds
WO2005085249A1 (en) 2004-02-27 2005-09-15 F. Hoffmann-La Roche Ag Fused derivatives of pyrazole
MXPA06012758A (es) * 2004-05-04 2007-01-16 Hormos Medical Ltd Novedosas formulaciones orales de ospemifeno.
US7939536B2 (en) 2004-12-28 2011-05-10 Aska Pharmaceutical Co., Ltd. Pyrimidinylisoxazole derivatives
JP2007039408A (ja) * 2005-08-05 2007-02-15 Unitec Foods Co Ltd 微粉化クレアチンとその製造方法

Similar Documents

Publication Publication Date Title
JP2010120974A5 (https=)
AU2014219283C1 (en) Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
RU2003114752A (ru) Лечение желудочно-кишечных стромальных опухолей
RU2439068C2 (ru) Модуляторы mglur5
US20080207572A1 (en) Use of Dual C-Kit/Fgfr3 Inhibitors for Treating Multiple Myeloma
JPWO2012144463A1 (ja) 腫瘍治療剤
JP2005519916A5 (https=)
JP2004512328A5 (https=)
JP2004534774A5 (https=)
JP2004517049A5 (https=)
RU2011103741A (ru) Композиции и способы лечения заболевания сетчатки
JP2017502068A5 (https=)
JP2012530765A5 (https=)
JP2017530187A5 (https=)
JP2007510665A5 (https=)
JP2007528379A5 (https=)
JP2020516671A5 (https=)
JP2005500363A5 (https=)
JP2011510055A5 (https=)
IL205501A (en) Preparation of preparations for the treatment of arthritis
JP2014502979A5 (https=)
JP2008508214A (ja) 女性の性障害の治療用ピペラジン誘導体
JP2020510693A5 (https=)
JP2010521516A5 (https=)
RU2005117374A (ru) Индолы, полезные для лечения заболеваний, связанных с андрогеновыми рецепторами